Use of monoclonal antibodies to dissect specificity and pathogenesis of antiphospholipid antibodies

Lupus

Volumn 19, Issue 4, 2010, Pages 359-364

  Lambrianides, A ^a   Giles, I P ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Antiphospholipid Syndrome; Monoclonal antibodies; Pathogenesis

Indexed keywords

BETA2 GLYCOPROTEIN 1; CELL ADHESION MOLECULE; IMMUNOGLOBULIN G; LIPOCORTIN 2; LIPOCORTIN 5; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 4C5; MONOCLONAL ANTIBODY CIC11; MONOCLONAL ANTIBODY CIC15; MONOCLONAL ANTIBODY CIC17; MONOCLONAL ANTIBODY CIC3; MONOCLONAL ANTIBODY CIC7; MONOCLONAL ANTIBODY CL1; MONOCLONAL ANTIBODY CL15; MONOCLONAL ANTIBODY CL24; MONOCLONAL ANTIBODY IS1; MONOCLONAL ANTIBODY IS2; MONOCLONAL ANTIBODY IS3; MONOCLONAL ANTIBODY IS4; PHOSPHOLIPID ANTIBODY; PROTEIN ANTIBODY; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

ANTIBODY AFFINITY; ANTIBODY COMBINING SITE; ANTIBODY ISOLATION; ANTIBODY SPECIFICITY; ANTIBODY STRUCTURE; ANTIGEN BINDING; ANTIPHOSPHOLIPID SYNDROME; COMPUTER MODEL; DISEASE MODEL; HUMAN; HYDROGEN BOND; IMMUNOPATHOGENESIS; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; REVIEW; SOMATIC MUTATION; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS;

AMINO ACID MOTIFS; AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, ANTIPHOSPHOLIPID; ANTIBODIES, MONOCLONAL; ANTIPHOSPHOLIPID SYNDROME; HUMANS; MOLECULAR SEQUENCE DATA; POINT MUTATION; PROTEIN BINDING;

EID: 77951216906     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/0961203309360809     Document Type: Review

References (17)

1. Miyakis S., Lockshin MD, Atsumi T., et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006 ; 4: 295-306.
2. Greaves M., Cohen H., Machin SH, Mackie I. Guidelines on the investigation and management of the antiphospholipid syndrome. Br J Haematol 2000 ; 109: 704-715. (Pubitemid 30609746)
3. Giannakopoulos B., Passam F., Rahgozar S., Krilis SA Current concepts on the pathogenesis of the antiphospholipid syndrome. Blood 2007 ; 109: 422-430. (Pubitemid 46105935)
4. Pierangeli SS, Chen PP, Gonzalez EB Antiphospholipid antibodies and the antiphospholipid syndrome: an update on treatment and pathogenic mechanisms. Curr Opin Hematol 2006 ; 13: 366-375.
5. Lieby P., Soley A., Levallois H., et al. The clonal analysis of anticardiolipin antibodies in a single patient with primary antiphospholipid syndrome reveals an extreme antibody heterogeneity. Blood 2001 ; 97: 3820-3828.
6. Giles I., Lambrianides A., Rahman A. Examining the non-linear relationship between monoclonal antiphospholipid antibody sequence, structure and function. Lupus 2008 ; 17: 895-903.
7. Rahman A., Haley J., Latchman DS Molecular expression systems for anti-DNA antibodies-1. Lupus 2002 ; 11: 824-832. (Pubitemid 36069978)
8. Chukwuocha R., Zhu M., Cho C., et al. Molecular and genetic characterizations of five pathogenic and two non-pathogenic monoclonal antiphospholipid antibodies. Mol Immunol 2002 ; 39: 299-311. (Pubitemid 35239887)
9. Lieby P., Poindron V., Roussi S. Pathogenic antiphospholipid antibody: an antigen-selected needle in a haystack. Blood 2004 ; 104: 1711-1715. (Pubitemid 39202278)
10. Giles I., Lambrianides N., Pattni N., et al. Arginine residues are important in determining the binding of human monoclonal antiphospholipid antibodies to clinically relevant antigens. J Immunol 2006 ; 177: 1729-1736. (Pubitemid 44092509)
11. Pierangeli SS, Liu X., Espinola R., et al. Functional analyses of patient-derived IgG monoclonal anticardiolipin antibodies using in vivo thrombosis and in vivo microcirculation models. Thromb Haemost 2000 ; 84: 388-395.
12. Vega-Ostertag M., Liu X., Kwan-Ki H., Chen P., Pierangeli S. A human monoclonal antiprothrombin antibody is thrombogenic in vivo and upregulates expression of tissue factor and E-selectin on endothelial cells. Br J Haematol 2006 ; 135: 214-219. (Pubitemid 44401619)
13. Jankowski M., Vreys I., Wittevrongel C., et al. Thrombogenicity of beta 2-glycoprotein I-dependent antiphospholipid antibodies in a photochemically induced thrombosis model in the hamster. Blood 2003 ; 101: 157-162. (Pubitemid 36025902)
14. Romay-Penabad Z., Montiel-Manzano MG, Shilagard T., et al. Annexin A2 is involved in antiphospholipid antibody-mediated pathogenic effects in vitro and in vivo. Blood 2009 ; 114: 3074-3083.
15. Testoni C., Bosisio D., et al. Role of the MyD88 transduction signaling pathway in endothelial activation by antiphospholipid antibodies. Blood 2003 ; 101: 3495-3500. (Pubitemid 36857933)
16. Ikematsu W., Luan FL, La Rosa L., et al. Human anticardiolipin monoclonal autoantibodies cause placental necrosis and fetal loss in BALB/c mice. Arthritis Rheum 1998 ; 41: 1026-1039. (Pubitemid 28265405)
17. Giles I., Pericleous C., Liu X., et al. Thrombin binding predicts the effects of sequence changes in a human monoclonal antiphospholipid antibody on its in vivo biologic actions. J Immunol 2009 ; 82: 4836-4843.